Matches in Wikidata for { <http://www.wikidata.org/entity/Q37684295> ?p ?o ?g. }
Showing items 1 to 83 of
83
with 100 items per page.
- Q37684295 description "article científic" @default.
- Q37684295 description "article scientifique" @default.
- Q37684295 description "articolo scientifico" @default.
- Q37684295 description "artigo científico" @default.
- Q37684295 description "artículu científicu espublizáu en 2014" @default.
- Q37684295 description "bilimsel makale" @default.
- Q37684295 description "scientific article published on 28 March 2014" @default.
- Q37684295 description "vedecký článok" @default.
- Q37684295 description "vetenskaplig artikel" @default.
- Q37684295 description "videnskabelig artikel" @default.
- Q37684295 description "vědecký článek" @default.
- Q37684295 description "wetenschappelijk artikel" @default.
- Q37684295 description "wissenschaftlicher Artikel" @default.
- Q37684295 description "наукова стаття, опублікована в березні 2014" @default.
- Q37684295 description "научни чланак" @default.
- Q37684295 description "գիտական հոդված հրատարակված 2014 թվականի մարտի 28-ին" @default.
- Q37684295 description "مقالة علمية نشرت في 28 مارس 2014" @default.
- Q37684295 name "Management of digital vasculopathy in systemic sclerosis: benefits of multiple courses of endothelin-1 receptor antagonists" @default.
- Q37684295 name "Management of digital vasculopathy in systemic sclerosis: benefits of multiple courses of endothelin-1 receptor antagonists" @default.
- Q37684295 name "Management of digital vasculopathy in systemic sclerosis: benefits of multiple courses of endothelin-1 receptor antagonists" @default.
- Q37684295 type Item @default.
- Q37684295 label "Management of digital vasculopathy in systemic sclerosis: benefits of multiple courses of endothelin-1 receptor antagonists" @default.
- Q37684295 label "Management of digital vasculopathy in systemic sclerosis: benefits of multiple courses of endothelin-1 receptor antagonists" @default.
- Q37684295 label "Management of digital vasculopathy in systemic sclerosis: benefits of multiple courses of endothelin-1 receptor antagonists" @default.
- Q37684295 prefLabel "Management of digital vasculopathy in systemic sclerosis: benefits of multiple courses of endothelin-1 receptor antagonists" @default.
- Q37684295 prefLabel "Management of digital vasculopathy in systemic sclerosis: benefits of multiple courses of endothelin-1 receptor antagonists" @default.
- Q37684295 prefLabel "Management of digital vasculopathy in systemic sclerosis: benefits of multiple courses of endothelin-1 receptor antagonists" @default.
- Q37684295 P1433 Q37684295-1706E438-0FB8-4B0E-B882-4E3E27BC0C85 @default.
- Q37684295 P1476 Q37684295-7ABB44B9-81F7-43FB-9E32-FCF276237BA1 @default.
- Q37684295 P2093 Q37684295-74682E05-614F-4C49-B213-EE51CA89717F @default.
- Q37684295 P2093 Q37684295-84B4EB15-E618-4550-AC17-56160AB02796 @default.
- Q37684295 P2860 Q37684295-15CF23C5-07C0-4DD5-932B-7230B07DFC31 @default.
- Q37684295 P2860 Q37684295-1A83A6BC-7F05-4178-AACC-A7AEA3DE3B10 @default.
- Q37684295 P2860 Q37684295-3F111C7A-B902-45E0-92F9-40763ADA7CA7 @default.
- Q37684295 P2860 Q37684295-4647B6FE-F912-4118-A4EB-EDC5551A56F4 @default.
- Q37684295 P2860 Q37684295-4DE720BE-C85C-4118-A6F9-A13A1F523916 @default.
- Q37684295 P2860 Q37684295-91071531-62EF-4EA2-A34D-3CCFA5BD65F2 @default.
- Q37684295 P2860 Q37684295-996798BC-DBBD-4CDB-8AF4-BACC63C68159 @default.
- Q37684295 P2860 Q37684295-9FB7C604-0247-44F5-AD23-CB31B35903B7 @default.
- Q37684295 P2860 Q37684295-A2D0B0EC-97DE-4DE4-A647-84D26538637C @default.
- Q37684295 P2860 Q37684295-B3E08EFF-1675-4EC6-AE05-31DC619933A9 @default.
- Q37684295 P2860 Q37684295-B8ED8B58-982C-48DB-BAA7-2EFD50E68A71 @default.
- Q37684295 P2860 Q37684295-C80EC4C1-C509-43FF-A76F-F615BF11DC3B @default.
- Q37684295 P2860 Q37684295-D838C1D7-3826-4253-8FE5-E2F3B6969D18 @default.
- Q37684295 P2860 Q37684295-FCB8656D-257D-4112-9C1D-7494959EB7A0 @default.
- Q37684295 P2860 Q37684295-FD426130-D84E-4B09-950B-71C58CEBF244 @default.
- Q37684295 P31 Q37684295-2a02abb9-5a27-43dd-82ed-bf8d622fb861 @default.
- Q37684295 P31 Q37684295-5B8D6F0B-85E2-49CF-A909-EB563D9C764D @default.
- Q37684295 P356 Q37684295-3BC47156-FE1A-41BD-A64A-42A3D6DCE33A @default.
- Q37684295 P478 Q37684295-E66F0552-D9E7-45C9-A0BB-08165B20C583 @default.
- Q37684295 P50 Q37684295-1BEF4BA0-3295-4975-97B9-7F382F7559A7 @default.
- Q37684295 P577 Q37684295-B27BFAD7-9D73-4D6E-835B-53C32AB0071A @default.
- Q37684295 P698 Q37684295-E8A02A69-263C-4B9C-9EF9-C9B80111512A @default.
- Q37684295 P932 Q37684295-10AD9EE3-1279-4745-820A-C8ECBD205DD7 @default.
- Q37684295 P356 BCR-2013-203174 @default.
- Q37684295 P698 24682137 @default.
- Q37684295 P1433 Q27723081 @default.
- Q37684295 P1476 "Management of digital vasculopathy in systemic sclerosis: benefits of multiple courses of endothelin-1 receptor antagonists" @default.
- Q37684295 P2093 "Christopher Paul Denton" @default.
- Q37684295 P2093 "Voon Ong" @default.
- Q37684295 P2860 Q34409802 @default.
- Q37684295 P2860 Q35953368 @default.
- Q37684295 P2860 Q36115785 @default.
- Q37684295 P2860 Q37504291 @default.
- Q37684295 P2860 Q38119242 @default.
- Q37684295 P2860 Q39702715 @default.
- Q37684295 P2860 Q39820228 @default.
- Q37684295 P2860 Q39863989 @default.
- Q37684295 P2860 Q39874145 @default.
- Q37684295 P2860 Q39887403 @default.
- Q37684295 P2860 Q39985450 @default.
- Q37684295 P2860 Q40087579 @default.
- Q37684295 P2860 Q45945562 @default.
- Q37684295 P2860 Q46413425 @default.
- Q37684295 P2860 Q46761996 @default.
- Q37684295 P31 Q13442814 @default.
- Q37684295 P31 Q2782326 @default.
- Q37684295 P356 "10.1136/BCR-2013-203174" @default.
- Q37684295 P478 "2014" @default.
- Q37684295 P50 Q63368248 @default.
- Q37684295 P577 "2014-03-28T00:00:00Z" @default.
- Q37684295 P698 "24682137" @default.
- Q37684295 P932 "3975530" @default.